批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/01/13 |
SUPPL-85(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/02/05 |
SUPPL-84(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2016/12/16 |
SUPPL-79(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2015/02/03 |
SUPPL-78(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2011/07/19 |
SUPPL-77(补充) |
Approval |
REMS |
N/A
|
|
|
2010/06/07 |
SUPPL-76(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2009/04/23 |
SUPPL-75(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2003/03/13 |
SUPPL-70(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/08/28 |
SUPPL-69(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/02/07 |
SUPPL-62(补充) |
Approval |
Labeling |
|
|
|
2002/02/07 |
SUPPL-59(补充) |
Approval |
Labeling |
|
|
|
1999/08/04 |
SUPPL-67(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/05/08 |
SUPPL-68(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1996/11/05 |
SUPPL-66(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1988/11/08 |
SUPPL-64(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1987/11/05 |
SUPPL-60(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1987/08/13 |
SUPPL-58(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1987/01/08 |
SUPPL-57(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1986/11/14 |
SUPPL-56(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1986/08/29 |
SUPPL-55(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1986/06/16 |
SUPPL-53(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1985/08/26 |
SUPPL-54(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1984/02/27 |
SUPPL-52(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1981/01/29 |
SUPPL-39(补充) |
Approval |
Efficacy |
|
|
|
1980/10/28 |
SUPPL-45(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1980/09/08 |
SUPPL-44(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1980/07/14 |
SUPPL-43(补充) |
Approval |
Labeling |
|
|
|
1980/03/10 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1979/12/12 |
SUPPL-40(补充) |
Approval |
Labeling |
|
|
|
1979/07/09 |
SUPPL-29(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1979/06/07 |
SUPPL-36(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1979/06/07 |
SUPPL-35(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1979/06/07 |
SUPPL-34(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1979/06/05 |
SUPPL-37(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1979/05/31 |
SUPPL-38(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1978/12/06 |
SUPPL-33(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1978/05/05 |
SUPPL-31(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1978/04/17 |
SUPPL-32(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1977/10/21 |
SUPPL-30(补充) |
Approval |
Labeling |
|
|
|
1977/10/20 |
SUPPL-28(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1977/03/18 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1977/01/04 |
SUPPL-24(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1976/12/21 |
SUPPL-25(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1976/12/21 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1976/08/04 |
SUPPL-16(补充) |
Approval |
Labeling |
|
|
|
1976/08/04 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1976/07/30 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1976/05/07 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1975/11/13 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1975/11/05 |
SUPPL-13(补充) |
Approval |
Labeling |
|
|
|
1975/09/10 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1975/03/31 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1972/06/23 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:CLORAZEPATE DIPOTASSIUM 剂型/给药途径:TABLET;ORAL 规格:7.5MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
017105 |
007 |
NDA |
TRANXENE |
CLORAZEPATE DIPOTASSIUM |
TABLET;ORAL |
7.5MG |
Prescription |
Yes |
No |
AB |
Approved Prior to Jan 1, 1982
|
AJENAT PHARMS |
071858 |
003 |
ANDA |
CLORAZEPATE DIPOTASSIUM |
CLORAZEPATE DIPOTASSIUM |
TABLET;ORAL |
7.5MG |
Prescription |
No |
No |
AB |
1987/07/17
|
AUROBINDO PHARMA |
075731 |
002 |
ANDA |
CLORAZEPATE DIPOTASSIUM |
CLORAZEPATE DIPOTASSIUM |
TABLET;ORAL |
7.5MG |
Prescription |
No |
No |
AB |
2000/04/27
|
TARO |
215566 |
002 |
ANDA |
CLORAZEPATE DIPOTASSIUM |
CLORAZEPATE DIPOTASSIUM |
TABLET;ORAL |
7.5MG |
Prescription |
No |
No |
AB |
2022/06/14
|
COREPHARMA |
213730 |
002 |
ANDA |
CLORAZEPATE DIPOTASSIUM |
CLORAZEPATE DIPOTASSIUM |
TABLET;ORAL |
7.5MG |
Prescription |
No |
No |
AB |
2022/06/16
|
NOVITIUM PHARMA |